Epinephrine and dopamine colocalization with norepinephrine in various peripheral tissues: guanethidine effects.
Chemical sympathectomy with guanethidine (Gnt) selectively destroys the postganglionic noradrenergic neurons, whereas dopaminergic fibers and nonneural catecholamine-secreting cells are spared. As a result, the relative proportions of norepinephrine (NE), epinephrine (E), and dopamine (DA) in tissues can be differentially affected. This study was done to show the possible differences in the relative amount of catecholamines in some organs and tissues that might indicate the nature of the secretory cells from which they originate. The contents of NE, E, and DA were assessed in rats neonatally treated with Gnt. Gnt-treated rats showed significantly lower levels of NE (P < 0.01) in all tissues except the adrenal gland and paraganglia. Epinephrine was present in all tissues with mean levels below 25 ng/g, with the exception of the adrenal gland (700 microg/gland) and paraganglia (100 ng/g). Only the heart showed lower values in Gnt-treated rats. Mean DA levels were also very high in paraganglia (530 ng/g). In the Gnt-treated rats, DA levels fell practically to zero except in the duodenum, mesentery, and adrenal, whereas there were high levels in the paraganglia, which were significantly different from controls. The results suggest that the three catecholamines are contained mainly in noradrenergic sympathetic fibers of muscle, white adipose tissue, heart, liver, pancreas, and spleen. The duodenum and mesentery may have dopaminergic fibers or E- and DA-containing nonneural cells. Hepatic-vagus paraganglia contain all the catecholamines in relatively high amounts in nonneural cells, and Gnt treatment raises DA levels without affecting the other amines.
Villanueva
Iván
I
Departamento de Fisiología, Escuela Nacional de Ciencias Biológicas, Col. Casco de Sto. Tomás, México. ivillanu@ipn.mx
Piñón
Manuel
M
Quevedo-Corona
Lucía
L
Martínez-Olivares
Rubén
R
Racotta
Radu
R
D002001:Adipose Tissue, Brown / Q000378:metabolism; D000818:Animals; D000831:Animals, Newborn; D002395:Catecholamines / Q000378:metabolism*; D004298:Dopamine / Q000378:metabolism; D004837:Epinephrine / Q000378:metabolism; D005260:Female; D005728:Ganglia, Sympathetic / Q000187:drug effects / Q000378:metabolism*; D006145:Guanethidine; D018482:Muscle, Skeletal / Q000378:metabolism; D009638:Norepinephrine / Q000378:metabolism; D010233:Paraganglia, Chromaffin / Q000378:metabolism; D051381:Rats; D017208:Rats, Wistar; D013563:Sympathectomy, Chemical; D014630:Vagus Nerve / Q000378:metabolism; D014781:Viscera / Q000378:metabolism*
D002395:Catecholamines; D004298:Dopamine; D009638:Norepinephrine; D004837:Epinephrine; D006145:Guanethidine